Artificial Intelligence for Multi-omics Analysis Part B, Volume 222 in the Progress in Molecular Biology and Translational Science series, highlights recent advances, with this new volume presenting chapters on a variety of topics, including Artificial Intelligence in multi-omics analysis of small molecule drug discovery, AI in multi-omics analysis in antimicrobial resistance, Artificial Intelligence and multi-Omics Approach in Vaccine Development, Artificial Intelligence in multi-omics Analysis of heart diseases, Artificial Intelligence in multi-omics Analysis of Kidney Diseases, Artificial Intelligence in multi-omics Analysis of Gastrointestinal Diseases, AI in multi-omics analysis in Stem cell research, and AI in multi-omics analysis in cancer, and more.
Additional sections cover AI in multi-omics analysis in obstructive lung diseases, AI in multi-omics analysis in neurodiseases, AI in multi-omics analysis in autoimmune diseases, AI in multi-omics analysis of liver diseases, AI in multi-omics analysis of COVID-19 patient data, and AI in multi-omics analysis of Type 2 diabetes.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. xv 7. Preface - p. xix 8. Chapter One: Artificial intelligence in multi-omics analysis of small-molecule drug discovery - p. 1 9. Chapter Two: AI in multi-omics analysis in AMR - p. 27 10. Chapter Three: Artificial intelligence in multi-omics analysis of heart diseases - p. 53 11. Chapter Four: Artificial intelligence-driven multi-omics analysis of gut-kidney axis in chronic kidney disease - p. 85 12. Chapter Five: Artificial intelligence in multi-omics analysis of gastrointestinal diseases - p. 111 13. Chapter Six: AI in multi-omics analysis in stem cell research - p. 129 14. Chapter Seven: AI in multi-omics analysis in cancer - p. 143 15. Chapter Eight: AI in multi-omics analysis in obstructive lung diseases - p. 165 16. Chapter Nine: Artificial intelligence in multi-omics analysis of neurological diseases - p. 207 17. Chapter Ten: AI in multi-omics analysis in viral diseases - p. 229 18. Chapter Eleven: AI in multi-omics analysis of liver diseases - p. 241 19. Chapter Twelve: AI in multi-omics analysis of COVID-19 patient data - p. 261 20. Chapter Thirteen: AI in multi-omics analysis of type 2 diabetes - p. 295 21. Index - p. 327
Artificial Intelligence for Multi-omics Analysis Part B, Volume 222 in the Progress in Molecular Biology and Translational Science series, highlights recent advances, with this new volume presenting chapters on a variety of topics, including Artificial Intelligence in multi-omics analysis of small molecule drug discovery, AI in multi-omics analysis in antimicrobial resistance, Artificial Intelligence and multi-Omics Approach in Vaccine Development, Artificial Intelligence in multi-omics Analysis of heart diseases, Artificial Intelligence in multi-omics Analysis of Kidney Diseases, Artificial Intelligence in multi-omics Analysis of Gastrointestinal Diseases, AI in multi-omics analysis in Stem cell research, and AI in multi-omics analysis in cancer, and more.
Additional sections cover AI in multi-omics analysis in obstructive lung diseases, AI in multi-omics analysis in neurodiseases, AI in multi-omics analysis in autoimmune diseases, AI in multi-omics analysis of liver diseases, AI in multi-omics analysis of COVID-19 patient data, and AI in multi-omics analysis of Type 2 diabetes.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. xv 7. Preface - p. xix 8. Chapter One: Artificial intelligence in multi-omics analysis of small-molecule drug discovery - p. 1 9. Chapter Two: AI in multi-omics analysis in AMR - p. 27 10. Chapter Three: Artificial intelligence in multi-omics analysis of heart diseases - p. 53 11. Chapter Four: Artificial intelligence-driven multi-omics analysis of gut-kidney axis in chronic kidney disease - p. 85 12. Chapter Five: Artificial intelligence in multi-omics analysis of gastrointestinal diseases - p. 111 13. Chapter Six: AI in multi-omics analysis in stem cell research - p. 129 14. Chapter Seven: AI in multi-omics analysis in cancer - p. 143 15. Chapter Eight: AI in multi-omics analysis in obstructive lung diseases - p. 165 16. Chapter Nine: Artificial intelligence in multi-omics analysis of neurological diseases - p. 207 17. Chapter Ten: AI in multi-omics analysis in viral diseases - p. 229 18. Chapter Eleven: AI in multi-omics analysis of liver diseases - p. 241 19. Chapter Twelve: AI in multi-omics analysis of COVID-19 patient data - p. 261 20. Chapter Thirteen: AI in multi-omics analysis of type 2 diabetes - p. 295 21. Index - p. 327
